Aurinia Pharmaceuticals Inc. (AUPH) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Corporate company logo of Aurinia Pharmaceuticals Inc (AUPH)

Aurinia Pharmaceuticals (AUPH) is implementing ESG standards in the production of immunosuppressants to reduce harmful emissions. However, fierce competition from industry behemoths and the risk of generic entry are creating pressure. The temporary trajectory of the EV/EBITDA multiple on the GURU.Markets chart confirms this, where the value 10.21 represents the latest figure. Stable cash flow from sales of the lupus nephritis drug supports the asset's current valuation.

AUPH Aurinia Corp: Enterprise Value to EBITDA Ratio in the range 11/23/2025 - 11/15/2026

Aurinia Pharmaceuticals Inc. - analytical breakdowns and key metrics (AUPH)

- current price and projected stock value:
Initial company analysis:Aurinia Corp AUPH
Original product of auriniapharma.com

Strategic partnerships for Aurinia Pharmaceuticals (AUPH) to commercialize lupus nephritis therapy require significant capital expenditures, making business valuation analysis critical. The EV/EBITDA multiple trend, reflecting the ratio of enterprise value including net debt to operating profit, allows for an assessment of the real value of assets and determines the extent of the issuer's undervaluation relative to its market liquidity.

Competitors of Aurinia Pharmaceuticals

EV/EBITDA Multiple ARGX (argenx.com)|Total Company Value to Operating Income Before Depreciation Ratio biontech.de (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ADMA Biologics Inc (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist Corp (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant, Inc.|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple grifols.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies Corp (ADPT)|Celldex Therapeutics, Inc. - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple BCRX (biocryst.com)|Vera Therapeutics, Inc. (VERA) - Company Value to EBITDA|Dianthus Therapeutics, Inc. - EV/EBITDA Multiple|Company Value to Operating Income Before Depreciation Ratio PHVS|ABCL: EV/EBITDA Multiple|Company Value to EBITDA Tourmaline Corp (TRML)|PGEN (precigen.com) - EV/EBITDA Multiple|EV/EBITDA Multiple Pharming Corp|Enterprise Value to EBITDA Ratio NKTR (Nektar)|UPB (Upstream Bio Inc) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zenas Bio ZBIO|IMNM: Enterprise Value to Operating Income Before Depreciation|GOSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio KalVista Pharmaceuticals KALV|Septerna (SEPN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|pieris.com - Business Value to Operating Income Before Depreciation|SVRA (Savara Inc) - EV/EBITDA Multiple|RIGL: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ANAB|ATXS (Astria Pharma) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization enGene Holdings Inc. ENGN|EV/EBITDA Multiple RAPT Therapeutics Inc. RAPT|Aerovate Therapeutics - EV/EBITDA Multiple|Company Value to EBITDA Aclaris Therapeutics Inc.|Kyverna (KYTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Tiziana Life Sciences (TLSA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cabaletta Bio Inc.|Ventyx Biosciences (VTYX) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple THTX|EV/EBITDA Multiple Avalo Therapeutics Inc. (AVTX)|EV/EBITDA Multiple ELDN (eledon.com)|AGEN - Enterprise Value to EBITDA Ratio|CLYM: Enterprise Value to EBITDA Ratio|ZURA (Zura Bio Limited) - Enterprise Value to Operating Income Before Depreciation|ATYR: EV/EBITDA Multiple|Adagene (ADAG) - EV/EBITDA Multiple|IMA (ikenaoncology.com) - EV/EBITDA Multiple|shattucklabs.com (STTK) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium Inc (EQ)|Connect Pharma - Enterprise Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic, Inc. IMUX|ATRA - Enterprise Value to EBITDA Ratio|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|XFOR: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ACET: EV/EBITDA Multiple|Celularity Corp (CELU) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio|Barinthus Biotherapeutics plc (BRNS) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple KZR|SABS: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AKTX (Akari Therapeutics, Plc)|ENLV (Enlivex Therapeutics, Ltd.) - Company Value to Operating Income Before Depreciation Ratio|QTTB: Enterprise Value to EBITDA Ratio|GOVX - EV/EBITDA Multiple|Edesa Biotech Corp (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|IBIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization carismatx.com|XTLB: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics Inc. (BOLT)|HCWB (HCW Biologics) - Business Value to Operating Income Before Depreciation|Aptevo Therapeutics - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple AIM ImmunoTech Inc. AIM|Aditxt Inc. - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation GRI (GRI Bio, Inc.)|XORTX Therapeutics Inc (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio ReShape Lifesciences|Enterprise Value to EBITDA Ratio REVB|Indaptus Corp (INDP) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization scinai.com (SCNI)|Enterprise Value to EBITDA Ratio CalciMedica CALI|EV/EBITDA Multiple AFMD (affimed.com)|Allakos Inc. (ALLK) - Company Value to EBITDA|HOOKIPA - EV/EBITDA Multiple|IGMS (igmbio.com) - Enterprise Value to Operating Income Before Depreciation|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation OCEA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC BioPharm|Third Harmonic Bio Inc. (THRD) - Total Company Value to Operating Income Before Depreciation Ratio